RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > 2019 > 7 > MHRA Seeks Input on Patient, Public Engagement

MHRA Seeks Input on Patient, Public Engagement

Posted 15 July 2019 | By Michael Mezher 

MHRA Seeks Input on Patient, Public Engagement

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Monday opened a twelve-week public consultation to gather input on its approach to engaging the public, patients, caregivers and health care professionals.
“We want to adopt a more systematic approach to listening to and involving patients – ensuring that the patient voice is heard when safety issues, concerning medicines and medical devices, are identified and in the licensing of new medicines,” MHRA writes.
The consultation consists of a survey asking respondents about their current awareness of MHRA activities, as well as asking respondents to rate how effective the agency’s current communication practices are.
The survey also asks how respondents would like to see the agency communicate in the future and asks how patients and the public would like to participate in various aspects of regulatory decision-making.
The consultation is open until 7 October and can be completed by filling out an online questionnaire or by filling out a downloadable form and emailing it to the agency.
MRHA, Consultation

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.